Perrigo Company plc (NYSE: PRGO), an Ireland-based global provider of Consumer Self-Care Products, announced on Wednesday that its board of directors has declared a quarterly dividend of USD0.290 per share, payable on September 16, 2025, to shareholders of record on August 29, 2025. This amount is unchanged from the previous quarterly dividend.
Perrigo Company plc is a pure-play self-care company with over a century of experience in providing health and wellness solutions to consumers, primarily in North America and Europe.
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli